Dr. Jianming Qiu's lab specializes in developing innovative gene editing therapies for cystic fibrosis (CF), a genetic disorder affecting the lungs. The lab focuses on using advanced techniques like CRISPR and rAAV vectors to correct genetic mutations in patients. Their research aims to enhance gene therapy effectiveness, making it a feasible treatment option for all CF patients, regardless of their specific gene mutations.

Dr. Hubert M. Tse's lab focuses on improving islet transplantation for type 1 diabetes treatment by exploring innovative encapsulation methods. They aim to create a protective environment for pancreatic cells to prevent immune rejection, using a special coating that modulates immune responses. This research could lead to better outcomes for patients receiving islet transplants.